The number of patients, not only undergoing cancer treatment, but who are surviving their cancer treatment is increasing. In addition, cancer is increasingly a chronic disease, wherein patients are living longer, but with their cancer controlled, but never to be cured. Established therapies, surgery, radiotherapy and chemotherapy are continuously evolving, but they still cause significant morbidity and adverse dental/oral complications and manifestations. Newer therapies, such as the biologic agents, the small molecules agents (TKIs) and the immune-modifying agents are also resulting in unexpected dental/oral complications and adverse effects. The risk of Medication-Related Osteonecrosis of the Jaws (MRONJ) is also becoming more common. This day-long event will address the basic concepts regarding the management of cancer and how these can impact adversely on our patients’ dental and oral health and the safe delivery of dental treatment.

Topics include

• Ablative Surgery and Reconstruction for Head and Neck Cancer
• Head and Neck Radiotherapy
• Chemotherapy
• New and Novel Cancer Treatments
• Dental Care for the Head and Neck Cancer Survivor
• Dental Care for the Patient post Head and Neck Radiotherapy
• Dental Care for the Patient Undergoing Chemotherapy
• New and Novel Cancer Treatments – oral/dental manifestations and complications
• Medication Related Osteonecrosis of The Jaws (MRONJ)